Companies: 10,795·Total market cap: $144.5T
Tyra Biosciences, Inc.

Tyra Biosciences, Inc.

TYRANASDAQHealthcare● Active
$26.75
+$0.11(+0.41%)
Market Cap$1.6B
P/E Ratio
52W High$40.65
52W Low$8.98

Tyra Biosciences, Inc. (TYRA) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

tyra · stock forecast · 7 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 7 Wall Street analysts in the past 3 months

SellBuy

Buy

7 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
7
Hold
0
Sell
0
Strong Sell
0
Total: 7 · Buy rate: 100.0%

12-Month Price Target

High

$59.00

Consensus

$50.50

+88.8% upside

Low

$42.00

Median: $51.5 · Last Close: $26.75

The Tyra Biosciences, Inc. (TYRA) analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month TYRA price target is $50.50, representing +88.8% upside from the current price of $26.75.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $51 (88.8%)

Consensus Target

$50.50

88.8% upside

High Target

$59

120.6%

Low Target

$42

57.0%

Current Price

$26.75

as of today

Based on analyst price targets, the TYRA stock price prediction for the next 12 months ranges from $42 to $59. The consensus TYRA price forecast of $50.50 implies 88.8% upside from the current price of $26.75.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$25.415.00%

1-day model range: $25.25–$25.57. Peak: $25.57 (-5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$28+3.3%
2028$28+5.2%
2029$28+6.3%
2030$29+6.8%
2031+7.2%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

14%0%86%
2Buy
0Neutral
12Sell
RSI (14)15.4Oversold
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · TYRA · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$27.58SELL
MA 10$30.12SELL
MA 20$32.41SELL
MA 50$34.50SELL
MA 100$33.64SELL
MA 200$25.58BUY
Current $TYRA · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$27.84SELL
EMA 10$29.44SELL
EMA 20$31.31SELL
EMA 50$33.05SELL
EMA 100$31.77SELL
EMA 200$27.42SELL
Current $TYRA · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
HC Wainwright & Co.2026-05-14
Maintains
BuyBuy
Piper Sandler2026-03-20
Maintains
OverweightOverweight
HC Wainwright & Co.2026-02-17
Maintains
BuyBuy
Wedbush2026-02-13
Maintains
OutperformOutperform
Jefferies2026-02-03
Maintains
BuyBuy
Oppenheimer2026-02-03
Maintains
OutperformOutperform
Piper Sandler2026-01-23
Maintains
OverweightOverweight
Wedbush2025-12-16
Maintains
OutperformOutperform
HC Wainwright & Co.2025-08-22
Maintains
BuyBuy
HC Wainwright & Co.2025-07-01
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Tyra Biosciences, Inc. (TYRA) stock. Of the recent 49 rating actions, 2 were upgrades and 1 were downgrades. 7 analysts currently cover TYRA.

Analyst Recommendation Trends

Buy ratings11
Hold ratings00
Sell ratings00

TYRA analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$1M

↓ 92.5% YoY

Revenue Next Year

$7M

↑ 950.6% YoY

EPS This Year

$-2.61

EPS Next Year

$-2.85

↑ 9.1% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast TYRA EPS of $-2.61 for the current fiscal year, based on estimates from 11 analysts. The TYRA revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The TYRA stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus TYRA price target is $50.50 (+88.8% upside), with an analyst consensus of Buy.

The TYRA short-term stock prediction for tomorrow is $25.41 (-5.00%). The TYRA stock price prediction for 2027 estimates an average of $28. The TYRA stock prediction for 2030 projects a range of $27–$31.

Tyra Biosciences, Inc. trades on NASDAQ under the ticker TYRA. The TYRA stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

TYRA forecast · 8 questions

According to 7 Wall Street analysts, the average 12-month TYRA price target is $50.50, with a high forecast of $59.00 and a low of $42.00. The median price target is shown in the chart above when available. This implies +88.8% potential upside from the current price of $26.75.

TYRA price targetWhat is TYRA price targetTYRA analyst price targetTYRA 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.